Table 3 Coverage of Pneumococcal vaccines according to children and adult age groups
≤ 18 years n (%) | > 18 years n (%) | Total n (%) | |
|---|---|---|---|
Invasive pneumococcal isolates (n19 + 24 = 43) | |||
PCV13 | 12 (63.2) | 14 (58.3) | 26 (60.5) |
PCV15 | 12 (63.2) | 14 (58.3) | 26 (60.5) |
PCV20 | 14 (73.7) | 15 (62.5) | 29 (67.4) |
PPV23 | 15 (78.9) | 17 (70.8) | 32 (74.4) |
Non-invasive pneumococcal isolates (n 240 + 137 = 377) | |||
PCV13 | 144 (60) | 79 (57.7) | 223 (59.1) |
PCV15 | 149 (62.1) | 82 (59.9) | 231 (61.3) |
PCV20 | 158 (65.8) | 92 (67.2) | 250 (66.3) |
PPV23 | 164 (68.3) | 96 (70.1) | 260 (68.9) |
All pneumococcal isolates (n 259 + 161 = 420) | |||
PCV13 | 156 (60.2) | 93 (57.8) | 249 (59.3) |
PCV15 | 161 (62.2) | 96 (59.6) | 257 (61.2) |
PCV20 | 172 (66.4) | 107 (66.5) | 279 (66.4) |
PPV23 | 179 (69.1) | 113 (70.2) | 292 (69.5) |